Biggest News Aggregation in the World
📰 Social Performance Scale News

Social Performance Scale News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Social Performance Scale. Real-time updates on events, politics, business and more.

Minerva Neurosciences, Inc: Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

WALTHAM, Mass., Aug. 22, 2022(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that the
United States Helen Shik Remy Luthringer Frederick Ahlholm Minerva Neurosciences Exchange Commission

Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

WALTHAM, Mass., Aug. 22, 2022 -- Minerva Neurosciences, Inc. , a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today... | August 22, 2022
United States Helen Shik Remy Luthringer Frederick Ahlholm Minerva Neurosciences Exchange Commission

Digital medicine system may reduce schizophrenia symptoms

A digital medicine system appeared to improve clinical schizophrenia symptoms beyond the effects of oral pharmacotherapy alone, according to study results presented at Psych Congress. “This work uses data from a digital medicine system that consists of tablets of the atypical antipsychotic aripiprazole, embedded with an ingestible event marker,” J. Corey Fowler, PhD, director of
San Antonio United States New Jersey J Corey Fowler Joe Gramigna Psych Congress
Source: healio.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science